Literature DB >> 23100782

Effect of morphine on Mycobacterium smegmatis infection in mice and macrophages.

Raman Preet Singh1, Sarbjit Singh Jhamb, Prati Pal Singh.   

Abstract

The immunomodulatory effects of opioids are known in various infections. However, little is known about the effects of opioids in tuberculosis (TB). In the present study, we report the effects of morphine in Mycobacterium smegmatis infection in mice and macrophages. Morphine exerted a dose-dependent suppression of infection in vivo: 50 and 100 mg/kg morphine exerted significant (P<0.05) suppression whereas 5 mg/kg morphine showed no effect. Analogous to the in vivo effects, incubation of M. smegmatis-infected mouse peritoneal macrophages with morphine (100 μM) showed significant reduction in intramacrophage CFU counts. However, morphine did not show any direct antimycobacterial activity in broth dilution assay upto 100 μM concentration. Further, morphine-induced intramacrophage killing of M. smegmatis was abrogated by naloxone and aminoguanidine indicating the involvement of opioid-receptor activation and nitric oxide production in protective effects of morphine. In conclusion, morphine suppressed the progression of experimental TB in both mice and macrophage models.

Entities:  

Keywords:  Macrophages; Mice; Morphine; Mycobacterium smegmatis

Year:  2009        PMID: 23100782      PMCID: PMC3450022          DOI: 10.1007/s12088-009-0045-6

Source DB:  PubMed          Journal:  Indian J Microbiol        ISSN: 0046-8991            Impact factor:   2.461


  26 in total

1.  Synthetic peptide VKGFY and its cyclic analog stimulate macrophage bactericidal activity through non-opioid beta-endorphin receptors.

Authors:  E V Navolotskaya; A A Kolobov; E A Kampe-Nemm; T A Zargarova; N V Malkova; S B Krasnova; Yu A Kovalitskaya; V P Zav'yalov; V M Lipkin
Journal:  Biochemistry (Mosc)       Date:  2003-01       Impact factor: 2.487

2.  Leishmania donovani amastigote component-induced colony-stimulating factor production by macrophages: modulation by morphine.

Authors:  Priya Singal; Prati Pal Singh
Journal:  Microbes Infect       Date:  2005-01-22       Impact factor: 2.700

Review 3.  Evidence for central opioid receptors in the immunomodulatory effects of morphine: review of potential mechanism(s) of action.

Authors:  R D Mellon; B M Bayer
Journal:  J Neuroimmunol       Date:  1998-03-15       Impact factor: 3.478

4.  Morphine affects cytostatic activity of macrophages by the modulation of nitric oxide release.

Authors:  R Pacifici; M Minetti; P Zuccaro; D Pietraforte
Journal:  Int J Immunopharmacol       Date:  1995-09

5.  Modulation of the innate immune response to HSV-1 following acute administration of morphine: role of hypothalamo-pituitary-adrenal axis.

Authors:  Patricia A Sheridan; Jan A Moynihan
Journal:  J Neuroimmunol       Date:  2005-01       Impact factor: 3.478

Review 6.  Opioid therapy and immunosuppression: a review.

Authors:  Ricardo Vallejo; Oscar de Leon-Casasola; Ramsun Benyamin
Journal:  Am J Ther       Date:  2004 Sep-Oct       Impact factor: 2.688

7.  Rapid in vivo screening of experimental drugs for tuberculosis using gamma interferon gene-disrupted mice.

Authors:  Anne J M Lenaerts; Veronica Gruppo; Jason V Brooks; Ian M Orme
Journal:  Antimicrob Agents Chemother       Date:  2003-02       Impact factor: 5.191

8.  Immunomodulation by morphine in Plasmodium berghei-infected mice.

Authors:  P P Singh; S Singh; G P Dutta; R C Srimal
Journal:  Life Sci       Date:  1994       Impact factor: 5.037

9.  Multiplication and survival of tubercle bacilli in the organs of mice.

Authors:  C H PIERCE; R J DUBOS; W B SCHAEFER
Journal:  J Exp Med       Date:  1953-02-01       Impact factor: 14.307

View more
  2 in total

1.  The R753Q polymorphism in Toll-like receptor 2 (TLR2) attenuates innate immune responses to mycobacteria and impairs MyD88 adapter recruitment to TLR2.

Authors:  Goutham Pattabiraman; Rahul Panchal; Andrei E Medvedev
Journal:  J Biol Chem       Date:  2017-04-25       Impact factor: 5.157

2.  Active and latent tuberculosis among HIV-positive injecting drug users in Indonesia.

Authors:  Hinta Meijerink; Rudi Wisaksana; Mery Lestari; Intan Meilana; Lydia Chaidir; Andre J A M van der Ven; Bachti Alisjahbana; Reinout van Crevel
Journal:  J Int AIDS Soc       Date:  2015-02-16       Impact factor: 5.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.